Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.03M P/E - EPS this Y 93.20% Ern Qtrly Grth -
Income -16.7M Forward P/E -5.14 EPS next Y 107.40% 50D Avg Chg 1.00%
Sales 14.73M PEG - EPS past 5Y - 200D Avg Chg -58.00%
Dividend N/A Price/Book 0.25 EPS next 5Y - 52W High Chg -94.00%
Recommedations 1.50 Quick Ratio 0.91 Shares Outstanding 30.10M 52W Low Chg 50.00%
Insider Own 0.04% ROA -24.59% Shares Float 29.93M Beta 2.01
Inst Own 3.95% ROE -139.03% Shares Shorted/Prior 718.77K/271.72K Price 0.72
Gross Margin 53.61% Profit Margin -65.46% Avg. Volume 521,908 Target Price 2.60
Oper. Margin -21.41% Earnings Date May 9 Volume 111,973 Change -0.41%
About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

NovaBay Pharmaceuticals, Inc. News
05:59 AM NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
03/27/24 NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript
03/27/24 Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
03/26/24 NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
03/25/24 NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
03/14/24 NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
03/13/24 NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
01/30/24 NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
01/09/24 NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
12/06/23 NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
11/12/23 NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript
11/09/23 NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
11/02/23 NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
10/11/23 NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
10/02/23 NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
09/21/23 Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
09/14/23 NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
09/11/23 NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
08/15/23 NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2023 Earnings Call Transcript
08/11/23 Q2 2023 NovaBay Pharmaceuticals Inc Earnings Call
NBY Chatroom

User Image nicemove Posted - 30 minutes ago

$NBY a pure dumping. indicating split is coming... sad.. big drop

User Image KRaul Posted - 3 hours ago

$NBY on my radar for big run up soon

User Image DDGuy3040 Posted - 3 hours ago

$NBY 0.1. Next

User Image GermanBulle Posted - 5 hours ago

$NBY huuuuge pump and dump with a ton of shares. I bet outstanding shares increase again massive on that day. The thing is, happened with all of the last 3 news 🧐🧐🧐 fluffy News and 10M+ shares traded. In my eyes very very VERY fishy 🤬 again here ….. SEC

User Image smile1610 Posted - 5 hours ago

$NBY

User Image VrtcIl Posted - 6 hours ago

Float Rotation $NBY could be getting wild. The bigger the float rotation (count: 2) the bigger the volatility in both directions. If you have a position, adjust your stop to the average range. Gain: 6.1% Float: 6.3M Short Float: 2.4 %

User Image orange11 Posted - 6 hours ago

$NBY this went 60% this morning from yesterday's adds in low 7s, next to go is $AGRI

User Image Cincykid712 Posted - 7 hours ago

$NBY manipulation at its finest.

User Image jotilla Posted - 7 hours ago

$NBY what's going on.... any new news?

User Image GermanBulle Posted - 8 hours ago

$NBY news 4 dumping the next ton of shares . So Easy right. Poisoned stock!

User Image Doctwoplay Posted - 8 hours ago

$NBY pretty sure that in q2 they will be profitable, but until then the stock will be obliterated to oblivion. I will continue to buy a small amount every step (0.05, 0.025 etc..). We must face the reality, the old investors are very disappointed, they just lose every Penny on this. 2.6 M in net sales per Q and 2.4M in market cap...

User Image ben_jamin03 Posted - 8 hours ago

$NBY she wants to pop so bad after hrs should be fun.

User Image Vishalmistry Posted - 8 hours ago

$NBY weird

User Image PDiddy777 Posted - 10 hours ago

$NBY will it make or break?

User Image brotherearl Posted - 11 hours ago

$NBY looking like manipulating shorts won again. BULLS have no balls.

User Image DDGuy3040 Posted - 11 hours ago

$NBY NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

User Image GermanBulle Posted - 11 hours ago

$NBY okay I tell you something Shares outstanding: 36 Millions today (not 6 M, what idiots said 2day) Means without R/S 2 years ago we would have a float of 1.3 Billions . That is crazy ! Please correct me if I was wrong ! Think you can’t. Re-election of management in May 😁 oh yes 🥳

User Image GermanBulle Posted - 11 hours ago

$NBY it should be clear. A red close is coming. You will never learn .sorry

User Image Huskersnsaints Posted - 11 hours ago

$NBY Damn volume is good but they might take it red

User Image Eli1303 Posted - 11 hours ago

$INVO $NBY today explode!!!📈🚀🚀 now $SINT your turn 👀💪⏳️

User Image AdenTrade99 Posted - 11 hours ago

$NBY

User Image Alaa2531981 Posted - 11 hours ago

$NBY

User Image Daniel316 Posted - 12 hours ago

$NBY I'm surprised this didn't hit .1

User Image Ohfosho Posted - 12 hours ago

$NBY I want this stock to pop asap, but think we will need a quarter with profit to really see stars. It would be nice if they would report the total views they are getting from these influencers vs the cost. They did say it was efficient though. Youtube doesn't seem to have that much traction with less than 3k views across 14 videos. Tik tok has 172 vids with roughly a 100k views. Instagram has about 120 vids and 50k. Can one of these tik tokers get us some million view vids for all the eye lash extension girls to really blow the lid off this thing? Would be nice. https://www.tiktok.com/@avenovaeyecare?lang=en https://www.youtube.com/playlist?list=PLHeXxHEkC1JqO6QJ9EfQ7OldCHjxkF-p7 https://www.instagram.com/avenovaeyecare/reels/

User Image orange11 Posted - 12 hours ago

$NBY keep selling shorts... Will be burnt soon on this

User Image brotherearl Posted - 12 hours ago

$NBY ding, ding, time 4 BULLS 2 crush ! the shorts!!!!!!!!

User Image VrtcIl Posted - 12 hours ago

Float Rotation Looking at $NBY as it just made a new shares rotation (count: 1). For new entries wait for pullbacks to the moving averages. Would not enter on new highs. Gain: 6.1% Float: 6.3M Short Float: 2.4 %

User Image Scientwist Posted - 12 hours ago

$NBY shows promising growth in 2024 with a 13% revenue increase and a 64% surge in Avenova online sales. Through strategic social media marketing and the Avenova Ambassador program, leveraging influencers, NovaBay aims to expand its market reach. With a new European partnership indicating steps towards global expansion, and a focus on innovative eye health products, NovaBay is positioning itself for further growth. Amidst a competitive market, these strategies may enhance its presence in the eye health sector. #EyeHealth #GlobalExpansion

User Image Indyboogiedog Posted - 12 hours ago

$NBY bull trap, shorts clearly in control for some time now. Back down next week.

User Image Heretomakemoney_ Posted - 12 hours ago

$WISA $NBY Reports Preliminary Eyecare and Wound Care « Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Analyst Ratings
Ladenburg Thalmann Buy Aug 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Kunin Audrey Chief Product Office.. Chief Product Officer Dec 06 Sell 1.81 1 2 12/07/22
Kunin Jeffrey President, DERMAdoct.. President, DERMAdoctor, LLC Dec 06 Sell 1.81 1 2 12/07/22
Kunin Audrey Chief Product Office.. Chief Product Officer Nov 21 Sell 2.10490 5,960 12,545 1 12/05/22
Kunin Jeffrey President, DERMAdoct.. President, DERMAdoctor, LLC Nov 21 Sell 2.10490 5,960 12,545 1 12/05/22
Hall Justin CEO, GC and Director CEO, GC and Director Sep 14 Buy 0.15 10,000 1,500 83,172 09/16/22
Kunin Jeffrey President, DERMAdoct.. President, DERMAdoctor, LLC Sep 14 Sell 0.1582 291,368 46,094 208,632 09/16/22
Kunin Audrey Chief Product Office.. Chief Product Officer Sep 14 Sell 0.1582 291,368 46,094 208,632 09/16/22